# Madrigal Pharmaceuticals, Inc.: Form 8-K, filed Jun 1, 2021

- Company: [Madrigal Pharmaceuticals, Inc.](/companies/mdgl.md) (CIK 1157601)
- Form: 8-K
- Filed: 2021-06-01
- Accepted by EDGAR: Jun 1, 2021, 08:01 ET
- Period: 2021-06-01
- Accession: 0001193125-21-177871
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1157601/000119312521177871/d190382d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157601/000119312521177871/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157601/000119312521177871/d190382d8k.htm

Filed Jun 1, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-177871. Last ingested by Listed: Nov 6, 2026, 18:49 ET. No prices; not investment advice.
